132 related articles for article (PubMed ID: 8982677)
1. Molecular characterization of pharmacological properties of T-0509 for beta-adrenoceptors.
Sato Y; Kurose H; Isogaya M; Nagao T
Eur J Pharmacol; 1996 Nov; 315(3):363-7. PubMed ID: 8982677
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of pharmacological properties and selectivity of SWR-0315NA for beta3-adrenoceptors.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Nagatomo T
Biol Pharm Bull; 2004 May; 27(5):718-22. PubMed ID: 15133253
[TBL] [Abstract][Full Text] [Related]
3. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
4. Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.
Blin N; Nahmias C; Drumare MF; Strosberg AD
Br J Pharmacol; 1994 Jul; 112(3):911-9. PubMed ID: 7921620
[TBL] [Abstract][Full Text] [Related]
5. Relationship between desensitization and downregulation of beta-adrenoceptors in cardiac tissues after prolonged in vivo infusion of T-0509, a beta 1-adrenoceptor agonist.
Sato Y; Kurose H; Nagao T
Jpn J Pharmacol; 1997 Apr; 73(4):325-32. PubMed ID: 9165369
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
7. Selectivity and potency of agonists for the three subtypes of cloned human beta-adrenoceptors expressed in Chinese hamster ovary cells.
Yanagisawa T; Sato T; Yamada H; Sukegawa J; Nunoki K
Tohoku J Exp Med; 2000 Nov; 192(3):181-93. PubMed ID: 11249148
[TBL] [Abstract][Full Text] [Related]
8. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
Sillence MN; Matthews ML
Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenoceptor subtype activities of trimetoquinol derivatives: biochemical studies on human beta-adrenoceptors expressed in chinese hamster ovary cells.
Konkar AA; Vansal SS; Shams G; Fraundorfer PF; Zheng WP; Nikulin VI; De Los Angeles J; Fertel RH; Miller DD; Feller DR
J Pharmacol Exp Ther; 1999 Nov; 291(2):875-83. PubMed ID: 10525112
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
[TBL] [Abstract][Full Text] [Related]
11. Agonist effects of zinterol at the mouse and human beta(3)-adrenoceptor.
Hutchinson DS; Chernogubova E; Sato M; Summers RJ; Bengtsson T
Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):158-68. PubMed ID: 16601951
[TBL] [Abstract][Full Text] [Related]
12. Beta 3-adrenoceptor agonist-induced down-regulation of Gs alpha and functional desensitization in a Chinese hamster ovary cell line expressing a beta 3-adrenoceptor refractory to down-regulation.
Chambers J; Park J; Cronk D; Chapman C; Kennedy FR; Wilson S; Milligan G
Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):973-8. PubMed ID: 7980470
[TBL] [Abstract][Full Text] [Related]
13. Impaired activation of adenylyl cyclase in lung of the Basenji-greyhound model of airway hyperresponsiveness: decreased numbers of high affinity beta-adrenoceptors.
Emala CW; Aryana A; Hirshman CA
Br J Pharmacol; 1996 Aug; 118(8):2009-16. PubMed ID: 8864536
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and biochemical characterization of the beta-adrenergic signal transduction pathway in different segments of the respiratory tract.
Abraham G; Kottke C; Dhein S; Ungemach FR
Biochem Pharmacol; 2003 Sep; 66(6):1067-81. PubMed ID: 12963495
[TBL] [Abstract][Full Text] [Related]
15. Functional effects of long-term activation on human beta 2- and beta 3-adrenoceptor signalling.
Nantel F; Bouvier M; Strosberg AD; Marullo S
Br J Pharmacol; 1995 Mar; 114(5):1045-51. PubMed ID: 7780639
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of the alpha 2/beta-adrenoceptor-coupled adenylate cyclase system and their relationship with adrenergic responsiveness in hamster fat cells from different anatomical sites.
Dieudonne MN; Pecquery R; Giudicelli Y
Eur J Biochem; 1992 Apr; 205(2):867-73. PubMed ID: 1349284
[TBL] [Abstract][Full Text] [Related]
17. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
18. Discrepancies between the affinities of binding and action of the novel beta-adrenergic agonist BRL 37344 in rat brown adipose tissue.
Muzzin P; Seydoux J; Giacobino JP; Venter JC; Fraser C
Biochem Biophys Res Commun; 1988 Oct; 156(1):375-82. PubMed ID: 2902858
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals.
Persad S; Takeda S; Panagia V; Dhalla NS
J Mol Cell Cardiol; 1997 Feb; 29(2):545-58. PubMed ID: 9140814
[TBL] [Abstract][Full Text] [Related]
20. Carazolol: a potent, selective beta 3-adrenoceptor agonist.
Méjean A; Guillaume JL; Strosberg AD
Eur J Pharmacol; 1995 Nov; 291(3):359-66. PubMed ID: 8719421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
